Press Releases
- Medical Diagnostic Laboratories, L.L.C., Announces New Line of Dermatopathology Testing including Melanoma Hereditary Genetics.
- Medical Diagnostic Laboratories, L.L.C., Announces New Line of Urology Testing including Prostate Cancer and Renal Cancer Hereditary Genetics.
- Medical Diagnostic Laboratories, L.L.C., Expands Availability of Coronavirus Disease 2019 (COVID-19) Testing into New York and Increases Testing Capabilities.
- Medical Diagnostic Laboratories, L.L.C., Launches Serological Test for Coronavirus Disease 2019 (COVID-19) Antibodies in Human Serum.
- Medical Diagnostic Laboratories, L.L.C., Fights Tick- and Mosquito-borne Epidemic with New Comprehensive Testing for Vector-borne Disease.
- Genesis Biotechnology Group® Acquires Assets of 4path, Ltd to Expand their Diagnostic Branch
- Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests
- Medical Diagnostic Laboratories, L.L.C.’s The Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests
- Test Announcement for NY Only
- Test Announcement
- Test #: 435 Anaplasma phagocytophilum lgG/lgM by ELISA is no longer available
- Announcing new Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia trachomatis.
- ILADS: 13th annual scientific conference, Lyme & Other Tick-Borne Diseases: Microbial Persistence and Tick-Borne
- IPHCA: Illinois Primary Healthcare Association 2012 Annual Leadership Conference
- Mercer Regional Chamber of Commerce 2011 Award
- Announcing new testing for Aerobic Vaginitis (AV).
- A Complimentary Reflex Test to Determine Metronidazole Resistance in Trichomonas vaginalis.
- New Bacterial Vaginosis/Lactobacillus Profiling Assay
- New HPV-16 Status Test